🚀 New Breakthrough in Liver Cancer! 🌟
The CheckMate 9DW trial shows that Nivolumab + Ipilimumab significantly improves survival in unresectable #HCC compared to lenvatinib/sorafenib! 🧬💪
#Immunotherapy #CancerResearch #LiverCancer #Oncology 💉
